Mark Baer
Impact in
- Cancer Research top 10%
- NF-κB Signaling Pathways
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- NF-κB Signaling Pathways 5
- Oncology 6
- Cytokine Signaling Pathways and Interactions 6
- Co-authors
- Peter F. Johnson (9 shared papers)Richard Carroll Schwartz (6 shared papers)Simon C. Williams (5 shared papers)Allan Dillner (2 shared papers)Geoffrey T. Yarranton (8 shared papers)Christopher R. Bebbington (9 shared papers)Sergei A. Nedospasov (1 shared paper)Estefanı́a Claudio (1 shared paper)
- Journals
- Blood (5 papers)Journal of Biological Chemistry (5 papers)Molecular and Cellular Biology (3 papers)Growth Factors (1 paper)Infection and Immunity (1 paper)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Mark Baer
21 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 204
- Hematology 151
- Immunology 206
- Oncology 163
- Molecular Biology 435
Countries citing papers authored by Mark Baer
This map shows the geographic impact of Mark Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Baer more than expected).
Fields of papers citing papers by Mark Baer
This network shows the impact of papers produced by Mark Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Baer. The network helps show where Mark Baer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Baer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 172 | |
| 2 | 1998 | 164 | |
| 3 | 2013 | 134 | |
| 4 | 1997 | 122 | |
| 5 | 2008 | 105 | |
| 6 | Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. | 1998 | 87 |
| 7 | 2000 | 84 | |
| 8 | 1998 | 77 | |
| 9 | 2014 | 73 | |
| 10 | 2000 | 65 | |
| 11 | 2002 | 61 | |
| 12 | 2014 | 61 | |
| 13 | 1998 | 43 | |
| 14 | 2006 | 39 | |
| 15 | 1993 | 19 | |
| 16 | 2011 | 11 | |
| 17 | 2014 | 11 | |
| 18 | 2022 | 9 | |
| 19 | 1989 | 7 | |
| 20 | 2010 | 6 |
About Mark Baer
Mark Baer is a scholar working on Cancer Research, Oncology, Molecular Biology, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), NF-κB Signaling Pathways (5 papers), Genomics and Chromatin Dynamics (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Immune Response and Inflammation (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (204 citations), Hematology (151 citations), Immunology (206 citations), Oncology (163 citations) and Molecular Biology (435 citations). Mark Baer has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Peter F. Johnson, Richard Carroll Schwartz, Simon C. Williams, Allan Dillner, Geoffrey T. Yarranton, Christopher R. Bebbington, Sergei A. Nedospasov, Estefanı́a Claudio, Ulrich K. Siebenlist and Howard A. Young. Their work appears in journals such as Blood, Journal of Biological Chemistry, Molecular and Cellular Biology, Growth Factors and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.